Sign in

CIK 0001593899

  • Non-accelerated filer
  • Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
460574869
Phone
+1 857-284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion +41,333 91,461
2026-01-31 Foster Wayne EVP, Chief Accounting Officer Shares withheld for taxes −12,132 $4.24 $51K 79,329
2026-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion · Restricted Stock Units −33,333 0
2026-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion · Restricted Stock Units −8,000 0
2026-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +108,000 108,000
2025-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion +33,333 54,190
2025-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award +8,000 62,190
2025-01-31 Foster Wayne EVP, Chief Accounting Officer Shares withheld for taxes −12,062 $3.06 $37K 50,128
2025-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion · Restricted Stock Units −33,333 33,333
2025-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Restricted Stock Units +8,000 8,000
2025-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +120,100 120,100
2024-02-01 Foster Wayne EVP, Chief Accounting Officer Sale −12,477 $3.84 $48K 20,857
2024-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion +33,334 33,334
2024-01-31 Foster Wayne EVP, Chief Accounting Officer Exercise or conversion · Restricted Stock Units −33,334 66,666
2024-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +120,100 120,100
2023-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Restricted Stock Units +100,000 100,000
2023-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +140,000 140,000
2022-01-31 Foster Wayne EVP, Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2021-01-29 Foster Wayne Grant or award · Stock Option (Right to Buy) +71,750 71,750
2020-10-29 Foster Wayne Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 1 of 1 · 20 trades